Hi, guys. So I got the bad news today. My results came back and turn out my cancer has come back. I cried of course... I was shocked and in disbelief. I did everything for my body to avoid relapse but it seems very fragile. I don't know what will happen to me in a couple of days, weeks, or months. I don't even know if I could make it this time.
For APL who also relapsed, what's the procedure you underwent? Have you undergone a bone marrow transplant?
I know someone who is diagnosed with leukemia - I believe it's acute promyelocytic leukemia - and I was wondering if anyone knows what kind of drug will they be getting to treat it. I want to know because I heard that it's different, and requires special treatment. P.S. I'm not sure if this is the right subreddit for this. Thank you.
http://www.nasdaq.com/press-release/oncbiomune-cmo-producing-first-batch-of-tretinoin-for-acute-promyelocytic-leukemia-20170929-00552
By GlobeNewswire, September 29, 2017, 09:43:00 AM EDT
BATON ROUGE, La., Sept. 29, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of a proprietary cancer vaccine technology, targeted cancer therapies and commercialization of a portfolio of products internationally, is pleased to announce that it has successfully achieved development milestones in formulation and stability with tretinoin, also known as all-trans retinoic acid (ATRA), an oral drug for the treatment of Acute Promyelocytic Leukemia (APL). OncBioMune owns the commercialization rights for tretinoin throughout Mexico, Central America and Latin America.
PROCAPS S.A.S., the Company's contract manufacturing organization, is currently in the midst of manufacturing the first batch of tretinoin from its state-of-the-art cGMP facility in Colombia. OncBioMune has been advised that production remains on schedule for the planned product launch scheduled in 2018.
"Achieving development milestones with PROCAPS has us now making preparations for the tretinoin launch in Mexico early next year and subsequently into Central and Latin America where APL remains problematic," commented Andrew Kucharchuk, President at OncBioMune. "To have a partner like PROCAPS with their experience and leading production facility is invaluable in meeting our high standards on time and within budget."
There are currently no approved drugs in Mexico for the treatment of APL, an aggressive type of Acute Myeloid Leukemia in which there are too many immature blood-forming cells in the blood and bone marrow, which leads to a shortage of healthy white and red blood cells and platelets. In developed countries, APL is regarded as one of the more curable types of leukemia, with tretinoin a commonly prescribed part of the therapeutic regimen. However, little therapeutic progress has been made in developing countries to deliver a measurable benefit with respect to complete hematological remission and disease-free survival, as is highly possible with tretinoin in the treatment protocol.
Based upon these facts, OncBioMune believes it can emerge as a market leader in the treatment of APL in Mexico, Central and South America. Early financial models have the company expecting to g
... keep reading on reddit β‘
Thanks again!
Can someone explain this?
